A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

778

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

August 25, 2025

Study Completion Date

December 15, 2025

Conditions
Migraine
Interventions
DRUG

Rimegepant

Rimegepant

DRUG

Placebo

matching placebo

Trial Locations (49)

100044

Peking University People's Hospital, Beijing

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

100853

Chinese PLA General Hospital, Beijing

110067

The People's Hospital of Liaoning Province, Shenyang

130000

The First hospital of Jilin University, Changchun

The Second Hospital of Jilin University, Changchun

200040

Huashan Hospital Fudan University, Shanghai

200123

Shanghai East Hospital, Shanghai

210011

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

212001

Affiliated Hospital of Jiangsu University, Zhenjiang

214023

Wuxi People's Hospital, Wuxi

214043

Wuxi No. 2 People's Hospital, Wuxi

215004

The Second Affiliated Hospital of Soochow University, Suzhou

215006

The First Affiliated Hospital of Suzhou University, Suzhou

222002

The Second People's Hospital of Lianyungang, Lianyungang

225001

Subei People's Hospital of Jiangsu province, Yangzhou

230011

The Second People's hospital of Hefei, Hefei

250012

Qilu Hospital of Shandong University, Jinan

250013

Jinan Central Hospital, Jinan

252000

Liaocheng people's Hospital, Liaocheng

257099

Shengli Oilfield Central Hospital, Dongying

266042

Qingdao Central Hospital, Qingdao

272000

Affiliated Hospital of Jining Medical University, Jining

276034

Linyi People's Hospital, Linyi

276800

People's Hospital of Rizhao, Rizhao

300000

Tianjin Union Medical Center, Tianjin

310016

Sir Run Run Shaw Hospital, Hangzhou

325000

The First Affiliated Hosptial of Wenzhou Medical University, Wenzhou

337055

Pingxiang People's Hospital, Pingxiang

350025

The 900th Hospital of Joint Logistics Support Force, PLA, Fuzhou

400010

The fourth people's hospital of chongqing, Chongqing

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

404000

Chongqing University Three Gorges Hospital, Chongqing

410013

The Third Xiangya Hospital of Central South University, Changsha

430060

Renmin Hospital of Wuhan University, Wuhan

450014

People's Hospital of Zhengzhou, Zhengzhou

510180

Guangzhou First People's Hospital, Guangzhou

570311

Hainan General Hospital, Haikou

650000

The Second Affiliated hospital of Kunming Medical University, Kunming

650032

First Affiliated Hospital of Kunming Medical University, Kunming

710061

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

710068

Shaanxi Provincial People's Hospital, Xi'an

712000

Xianyang Hospital of Yan'an University, Xianyang

730030

Lanzhou university second hospital, Lanzhou

750003

General Hospital of Ningxia Medical Hospital, Yinchuan

050051

Hebei General Hospital, Shijiazhuang

014010

The First Affiliated Hospital of Baotou Medical College, Baotou

030001

The First Hospital of Shanxi Medical University, Taiyuan

046000

Heping Hospital Affiliated to Changzhi Medical College, Changzhi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY